Hedge Funds Aren t Crazy About Meridian Bioscience, Inc (VIVO) Anymore insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Operator
Good day, and welcome to the Benchmark Electronics, Inc. Second Quarter 2021 Earnings Conference Call. [Operator Instructions] [Operator Instructions].
I would now like to turn the conference over to Lisa Weeks, Chief Strategy Officer, Head of Investor Relations. Please go ahead.
Lisa Weeks
Senior VP, Chief Strategy Officer And Head of IR
Thank you, operator, and thanks, everyone, for joining us today for Benchmark s Second Quarter 2021 Earnings Call. Joining me this afternoon are Jeff Benck, CEO and President; and Roop Lakkaraju, CFO. After the market closed today, we issued an earnings release highlighting our financial performance for the second quarter of 2021, and we have prepared a presentation that we will reference on this call. The press release and presentation are available online under the Investor Relations section of our website at www.bench.com.
Benchmark Reports Second Quarter 2021 Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Naprotek Appoints New SVP of Business Development
Naprotek, LLC, the leading provider of high-reliability, quick-turn prototypes, and low-to-medium volumes PCBAs and box builds, announced the appointment of Jim Apfel as the Senior Vice President of Business Development.
In this role, Jim will direct Naprotek’s go-to-market organization with key responsibilities in sales leadership, key market direction and portfolio strategy. “Jim joins our senior leadership team at the ideal time,” said Daniel Everitt, CEO and President of Naprotek. “Jim brings valuable experience in high-reliability, mission-critical and life-sustaining markets across both EMS and OEM companies. He has built business development teams to accelerate revenues across a complex blend of engineered products, precision microelectronic assemblies and electronic manufacturing services.”
Were Hedge Funds Right About Repare Therapeutics Inc. (RPTX)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings disclosed the funds’ positions on March 31st. We at Insider Monkey have made an extensive database of more than 866 of those established hedge funds and famous value investors’ filings. In this article, we analyze how these elite funds and prominent investors traded Repare Therapeutics Inc. (NASDAQ:RPTX) based on those filings.